Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute Of Human Genetics Munich, |
RCV000011699 | SCV000608377 | pathogenic | Congenital adrenal hypoplasia, X-linked | 2017-10-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001851797 | SCV002302604 | likely pathogenic | Congenital adrenal hypoplasia, X-linked; 46,XY sex reversal 2 | 2021-09-02 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects NR0B1 function (PMID: 10848616, 11443184, 16459121, 20573681). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 10952). This missense change has been observed in individuals with X-linked congenital adrenal hypoplasia (PMID: 7990958, 21925982). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 267 of the NR0B1 protein (p.Arg267Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. |
OMIM | RCV000011699 | SCV000031931 | pathogenic | Congenital adrenal hypoplasia, X-linked | 2000-07-01 | no assertion criteria provided | literature only |